Lexicon Pharmaceuticals Inc (LXRX)

Jun 11, 2026

Lexicon Pharmaceuticals (LXRX) reports break-even earnings for Q1 - MSN

Jun 11, 2026

Jun 11, 2026

Is Lexicon Pharmaceuticals, Inc. (LXRX) A Good Stock To Buy Now? - Insider Monkey

Jun 11, 2026

Jun 11, 2026

Lexicon Pharmaceuticals vs Pfizer: Comparing a Small Biotech with a Global DrugmakerNews and Statistics - IndexBox

Jun 11, 2026

Jun 11, 2026

Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026? - Yahoo Finance

Jun 11, 2026

Jun 11, 2026

LXRX News | LEXICON PHARMACEUTICALS INC (NASDAQ:LXRX) - ChartMill

Jun 11, 2026

Jun 04, 2026

Lexicon Pharmaceuticals (LXRX) director converts 89,312 RSUs into common stock holdings - Stock Titan

Jun 04, 2026

Jun 04, 2026

Diane E. Sullivan converts 89,312 RSUs at Lexicon Pharmaceuticals (LXRX) - Stock Titan

Jun 04, 2026

Jun 04, 2026

[Form 4] LEXICON PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan

Jun 04, 2026

Jun 04, 2026

Lexicon Pharmaceuticals (LXRX) director exercises 89,312 RSUs into shares - Stock Titan

Jun 04, 2026

Jun 04, 2026

Lexicon Pharmaceuticals (LXRX) director converts 89,312 RSUs into 213,771-share stake - Stock Titan

Jun 04, 2026

Jun 04, 2026

Lexicon (NASDAQ: LXRX) director converts 89,312 restricted stock units into common stock - Stock Titan

Jun 04, 2026

Jun 04, 2026

Lexicon (NASDAQ: LXRX) director converts 89,312 RSUs into common stock, boosts stake - Stock Titan

Jun 04, 2026

Jun 04, 2026

LXRX: Pivotal HCM trial nears completion as pipeline and partnerships drive transformation - TradingView

Jun 04, 2026

Jun 04, 2026

How The Lexicon Pharmaceuticals (LXRX) Investment Narrative Is Evolving With Quiet Analyst Updates - Yahoo Finance

Jun 04, 2026

Jun 03, 2026

New Type 1 diabetes drug data from Lexicon at ADA 2026 meeting - Stock Titan

Jun 03, 2026

Jun 03, 2026

Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions - The Manila Times

Jun 03, 2026

Jun 02, 2026

LXRX Stock Chart | LEXICON PHARMACEUTICALS INC (NASDAQ:LXRX) - ChartMill

Jun 02, 2026

Jun 01, 2026

Lexicon (LXRX) Q1 2026 Earnings Transcript - The Globe and Mail

Jun 01, 2026

May 28, 2026

Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference - The Manila Times

May 28, 2026

May 28, 2026

Lexicon Pharma schedules Jefferies healthcare fireside chat for June 4 - Stock Titan

May 28, 2026

May 27, 2026

SA analyst upgrades/downgrades: SMCI, AMZN, SFM, LXRX - Seeking Alpha

May 27, 2026

May 26, 2026

Lexicon Pharmaceuticals: Uncertainty Clouds The Bull Case (Rating Downgrade) (NASDAQ:LXRX) - Seeking Alpha

May 26, 2026

May 22, 2026

Citi Raises its Price Target on Lexicon Pharmaceuticals (LXRX) - Insider Monkey

May 22, 2026

May 21, 2026

LXRX Stock Price, Quote & Chart | LEXICON PHARMACEUTICALS INC (NASDAQ:LXRX) - ChartMill

May 21, 2026

May 20, 2026

Apellis Pharmaceuticals (APLS) Surges 5.8%: Is This an Indication of Further Gains? - Eastern Progress

May 20, 2026

May 20, 2026

5 Best Penny Stocks to Buy for Long Term - Insider Monkey

May 20, 2026

May 17, 2026

Lexicon anticipates SONATA-HCM enrollment completion by mid-2026 while highlighting $100m Hercules debt facility - MSN

May 17, 2026

May 16, 2026

A Look At Lexicon Pharmaceuticals (LXRX) Valuation After Improved Q1 Revenue And Narrowed Net Loss - Sahm

May 16, 2026

May 15, 2026

Lexicon Pharmaceuticals: up to 50 percent of type 2 diabetes patients affected by painful neuropathy - Traders Union

May 15, 2026

May 15, 2026

Lexicon Pharmaceuticals, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LXRX) 2026-05-15 - Seeking Alpha

May 15, 2026

May 14, 2026

Navigating Life with Hypertrophic Cardiomyopathy - GlobeNewswire Inc.

May 14, 2026

May 14, 2026

Lexicon Pharmaceuticals (LXRX) Is Up 52.5% After Q1 Loss Narrows And Revenue JumpsHas The Bull Case Changed? - simplywall.st

May 14, 2026

May 13, 2026

Lexicon Pharmaceuticals (LXRX) Is Up 46.1% After Revenue Surges And Loss Narrows Sharply – What's Changed - Yahoo Finance

May 13, 2026

May 12, 2026

Lexicon Pharmaceuticals management to join Nasdaq HQ fireside chat - Traders Union

May 12, 2026

May 12, 2026

Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference - Herald and News

May 12, 2026

May 12, 2026

Fireside chat at Nasdaq HQ: Lexicon joins H.C. Wainwright investor event May 19 - Stock Titan

May 12, 2026

May 11, 2026

LXRX Maintained by Citigroup -- Price Target Raised to $3.10 - GuruFocus

May 11, 2026

May 11, 2026

$Lexicon Pharmaceuticals (LXRX.US)$ 🚀🚀🚀🚀🚀🤩🤩🤩🤩🤩 - Moomoo

May 11, 2026

May 11, 2026

Citigroup Issues Positive Forecast for Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Price - MarketBeat

May 11, 2026

May 11, 2026

Citi Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Raises Target Price to $3.1 - Moomoo

May 11, 2026

May 10, 2026

Lexicon (LXRX) Reports $21.1M Q1 Revenue Driven by Novo Nordisk Milestones - Yahoo Finance

May 10, 2026